Versarien Plc (LON:VRS) CEO Neill Ricketts talks to DirectorsTalk about the participation of the Company’s subsidiary, 2-DTech Ltd, in a new project funded by the EPSRC (Engineering and Physical Sciences Research Council). Neill explains the background to the new healthcare graphene project, talks about the areas in the bio-medical market they will be focusing on, how the healthcare laboratory and multinational partners will help in progressing the project and further opportunities to access grant monies.
Versarien plc, is an advanced materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries. 2-DTech Ltd. specialises in the supply, characterisation and early stage development of graphene products. EPSRC is the main UK government agency for funding research and training in engineering and the physical sciences, investing more than £800 million a year in a broad range of subjects – from mathematics to materials science, and from information technology to structural engineering.
